ArticleJournal of clinical and experimental hepatology

A Case of First-line Atezolizumab Plus Bevacizumab Use in Recurrence of Combined Hepatocellular Cholangiocarcinoma After Surgical Resection.

Gordon T Moffat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.